| 12331018 |
Pyrrolidine orexin receptor agonists |
Stephane L. Bogen, Michael J. Breslin, Dane Clausen, Michael T. Rudd, Shawn J. Stachel +2 more |
2025-06-17 |
|
| 12195445 |
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors |
Ashok Arasappan, Ian M. Bell, Michael J. Breslin, Christopher James Bungard, Christopher S. Burgey +11 more |
2025-01-14 |
|
| 11377438 |
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors |
Ashok Arasappan, Ian M. Bell, Michael J. Breslin, Christopher James Bungard, Christopher S. Burgey +11 more |
2022-07-05 |
$309,260,000 |
| 9833448 |
Piperidinone carboxamide azaindane CGRP receptor antagonists |
Ian M. Bell, Mark E. Fraley, Steven N. Gallicchio, Helen J. Mitchell, Daniel V. Paone +3 more |
2017-12-05 |
$49,639,000 |
| 9656990 |
Cathepsin cysteine protease inhibitors |
Shawn J. Stachel, Daniel V. Paone, Jing Li, Jianmin Fu, Shimin Xu |
2017-05-23 |
$97,197,000 |
| 9573913 |
Cathepsin cysteine protease inhibitors |
Shawn J. Stachel, Daniel V. Paone, Jing Li, John Lim, Jianmin Fu +1 more |
2017-02-21 |
$159,401,000 |
| 9499545 |
Piperidinone carboxamide azaindane CGRP receptor antagonists |
Ian M. Bell, Mark E. Fraley, Steven N. Gallicchio, Helen J. Mitchell, Daniel V. Paone +3 more |
2016-11-22 |
$87,862,000 |
| 9499541 |
Piperidinone carboxamide indane CGRP receptor antagonists |
Ian M. Bell, Mark E. Fraley, Steven N. Gallicchio, Helen J. Mitchell, Daniel V. Paone +4 more |
2016-11-22 |
$87,862,000 |
| 9067941 |
Fused heterocyclic azaindane carboxamide CGRP receptor antagonists |
Christopher S. Burgey, Ashley Nomland, Daniel V. Paone |
2015-06-30 |
$198,063,000 |
| 8912210 |
Piperidinone carboxamide azaindane CGRP receptor antagonists |
Ian M. Bell, Mark E. Fraley, Steven N. Gallicchio, Helen J. Mitchell, Daniel V. Paone +3 more |
2014-12-16 |
$161,344,000 |
| 8895572 |
Fused heterocyclic indane carboxamide CGRP receptor antagonists |
Christopher S. Burgey, Daniel V. Paone |
2014-11-25 |
$61,287,000 |
| 8883807 |
Piperidinone carboxamide indane CGRP receptor antagonists |
Ian M. Bell, Mark E. Fraley, Steven N. Gallicchio, Helen J. Mitchell, Daniel V. Paone +4 more |
2014-11-11 |
$48,775,000 |
| 8754096 |
Piperidinone carboxamide azaindane CGRP receptor antagonists |
Ian M. Bell, Mark E. Fraley, Steven N. Gallicchio, Helen J. Mitchell, Daniel V. Paone +4 more |
2014-06-17 |
$87,270,000 |
| 8598209 |
P2X3, receptor antagonists for treatment of pain |
Christopher S. Burgey, Zhengwu J. Deng, Diem N. Nguyen, Daniel V. Paone, Anthony W. Shaw |
2013-12-03 |
$75,696,000 |
